Weekly Regulatory Intelligence |
The EPA finalized tighter air pollution standards for large municipal waste combustors — incinerators that burn household trash to generate electricity — in response to a court-ordered remand, setting stricter limits on emissions of sulfur dioxide, nitrogen oxides, and particulate matter for both new facilities and existing plants. Separately, the State Department proposed enhanced vetting protocols for the diversity visa lottery program, adding biometric requirements and fraud detection measures that could slow processing times for the roughly 50,000 visas issued annually under the program. The SBA also rescinded a decades-old loan guarantee program for minority-owned businesses seeking DOE contracts, eliminating a regulatory pathway that had seen minimal utilization in recent years. |
This Week's Regulatory Activity 532 Reg. Notices | 323 Clinical Trials | | 532 Fed Register 323 Trials 9 Recalls |
|
📜 | Regulatory Notices | 17 of 532 this week |
|
Rule Environmental Protection Agency EPA published a voluntary remand response and five-year review of Standards of Performance for New Stationary Sources and Emission Guidelines for Existing Sources concerning Large Municipal Waste Combustors. The action addresses performance standards and emission guidelines for both new and existing municipal waste combustion facilities. →The EPA's voluntary remand of its 2006 large municipal waste combustor rule represents a rare instance of the agency proactively revisiting emissions standards outside the standard five-year review cycle. This action affects approximately 70 large waste-to-energy facilities nationwide that process municipal solid waste, potentially requiring updates to emissions monitoring systems and operating procedures. The combination of remand response and five-year review suggests the agency identified significant technical or legal deficiencies in the original rule's New Source Performance Standards (NSPS) and Emission Guidelines that warrant immediate correction rather than waiting for routine review. |
Rule Energy Department Department of Energy published a proposed rule rescinding regulations for loans to Minority Business Enterprises seeking DOE contracts and assistance. The action would eliminate the existing loan program regulatory framework. →The Department of Energy rarely rescinds longstanding contract assistance programs, making this withdrawal notable in federal procurement policy. The regulation, originally designed to facilitate DOE contracting access for minority-owned firms through loan guarantees, had been in place for decades with minimal agency modification. This rescission removes a specific financial mechanism that previously reduced barriers to federal energy contracts, though other Small Business Administration programs and DOE diversity initiatives remain in effect across the agency's $50+ billion annual procurement portfolio. |
Rule General Services Administration General Services Administration published a proposed rule updating the General Services Property Management Regulation (GSPMR) regarding nondiscrimination on the basis of age for programs receiving federal financial assistance. The action aligns GSA regulations with the Age Discrimination Act requirements. →GSA's regulatory update aligns federal property management rules with Age Discrimination Act requirements for programs receiving federal financial assistance. The action reflects the agency's periodic review of nondiscrimination compliance across its grant and assistance programs, ensuring consistency with civil rights enforcement standards established by the Department of Justice model regulations. |
Rule Agriculture Department USDA published a correction to the final rule concerning the Supplemental Disaster Relief Program and Dairy Margin Coverage Program. The correction addresses technical errors in the previously published regulation. →The USDA's correction to disaster relief and dairy margin coverage programs addresses administrative clarifications rather than substantive policy changes—typical of supplemental program guidance following initial implementation. These technical corrections ensure program consistency across field offices and resolve ambiguities that emerged during the first enrollment period, affecting payment calculations and eligibility determinations for producers who suffered losses in designated disaster years. |
Rule State Department Department of State published a proposed rule on enhancing vetting and combatting fraud in the Diversity Immigrant Visa Program. The action would strengthen verification procedures and fraud prevention measures for diversity visa applicants. →The State Department's announcement of enhanced vetting procedures for Diversity Visa applicants marks a significant tightening of documentary requirements and fraud detection protocols—the first major procedural overhaul to the DV lottery program since 2017. While this affects immigration processing rather than traditional drug or device regulation, the heightened scrutiny reflects broader government efforts to strengthen identity verification across federal benefit programs, particularly for the roughly 50,000 annual DV lottery selectees who must now navigate more rigorous documentation standards before consular interviews. |
Rule Health and Human Services Department CMS published a correction to the final rule establishing CY 2026 payment policies under the Physician Fee Schedule, Medicare Shared Savings Program requirements, and Medicare Prescription Drug Inflation Rebate Program provisions. The correction addresses technical errors in the previously published payment policies and coverage determinations. →CMS issues a correction to its CY 2026 Physician Fee Schedule final rule, suggesting technical amendments to previously published payment policies. These corrections—distinct from the substantive rule itself—typically address cross-reference errors, calculation clarifications, or regulatory text inconsistencies discovered post-publication. While procedural, such corrections can meaningfully affect how providers interpret reimbursement methodologies, particularly around evaluation and management codes, quality payment programs, or the newly implemented prescription drug inflation rebate calculations. |
Rule Environmental Protection Agency EPA published final approval of North Dakota's Air Quality Implementation Plans, including the Regional Haze State Implementation Plan, five-year progress report, and nitrogen oxides Best Available Retrofit Technology determination for Coal Creek Station for the first implementation period. The action finalizes state measures to address regional haze visibility impairment. →The EPA's approval of North Dakota's first-period regional haze plan marks a critical milestone in the state's compliance with the Regional Haze Rule, which requires measurable progress toward natural visibility conditions in Class I areas by 2064. The nitrogen oxides BART determination for Coal Creek Station—one of North Dakota's largest coal-fired facilities—establishes enforceable emission limits that will serve as baseline controls through 2028, when the second implementation period begins and more stringent measures may be required. |
Also This Week | Rules Regarding Delegation of Authority; Correction The agency issued a correction to previously published rules regarding delegation of authority. →The Department of Commerce is issuing a technical correction to clarify internal delegation procedures, a routine administrative update that carries no substantive policy changes. This type of correction typically addresses cross-referencing errors or formatting inconsistencies in previously published rules. |
| | Updating and Streamlining the Department of Commerce's Privacy Act Regulations; Correction The Department of Commerce issued a correction to its proposed rule updating and streamlining Privacy Act regulations. →Commerce is modernizing its Privacy Act regulations to align with current data protection practices and remove outdated provisions. The streamlining effort reflects broader federal agency efforts to update administrative procedures that predate digital recordkeeping systems. |
| | Revising the National Drug Code Format and Drug Label Barcode Requirements The FDA proposed revising the National Drug Code format and drug label barcode requirements to modernize pharmaceutical product identification standards. →FDA is proposing the most significant revision to drug identification standards in decades, requiring three-segment National Drug Codes and updated barcode formats to improve tracking throughout the pharmaceutical supply chain. The standardization addresses long-standing interoperability issues between manufacturer systems and pharmacy databases. |
| | National Standards for Traffic Control Devices; the Manual on Uniform Traffic Control Devices for Streets and Highways; Revision The Federal Highway Administration proposed revisions to the Manual on Uniform Traffic Control Devices for Streets and Highways, updating national standards for traffic control devices. →The Federal Highway Administration is undertaking a comprehensive update to the Manual on Uniform Traffic Control Devices, the foundational standard governing road signs, signals, and markings nationwide. MUTCD revisions typically occur on decade-plus cycles and impact state DOT specifications and municipal infrastructure procurement. |
| | BALL | Airworthiness Directives; Schempp-Hirth Flugzeugbau GmbH Gliders The FAA issued an airworthiness directive affecting Schempp-Hirth Flugzeugbau GmbH gliders, requiring compliance inspections or modifications. →FAA is issuing an airworthiness directive for Schempp-Hirth gliders, a German manufacturer whose sailplanes are used primarily in recreational soaring. The AD indicates a safety-related deficiency requiring inspection or modification across the affected fleet. |
| | | BA | Airworthiness Directives; The Boeing Company Airplanes The FAA issued an airworthiness directive affecting The Boeing Company airplanes, mandating safety-related inspections or design changes. →Boeing faces another airworthiness directive addressing safety concerns across its commercial airplane fleet. The frequency of Boeing ADs has intensified since 737 MAX certification issues, with FAA applying heightened scrutiny to design reviews and in-service monitoring. |
| | Removal of Regulations for Renewal Communities Designations The agency proposed removing regulations governing Renewal Communities designations, eliminating an expired economic development program framework. →Treasury is removing regulations for the Renewal Communities program, a tax incentive designation that expired in 2009. The cleanup eliminates obsolete regulatory text that no longer governs any active geographic designations. |
| | |
|
| Clinical Trials | 1 of 323 this week |
|
PHASE3 COMPLETED A Phase 3 multicenter, open-label, randomized study with single-arm extension period has been completed, assessing pharmacokinetics, safety, and efficacy of macitentan versus standard of care in children with pulmonary arterial hypertension. The trial evaluated the investigational therapy in the pediatric population with this rare cardiovascular condition. →Macitentan's pediatric Phase 3 trial completion marks a critical step toward expanding pulmonary arterial hypertension (PAH) treatment options for children, a population where therapeutic choices remain severely limited. The open-label design with extension period reflects FDA's pediatric study framework for rare diseases, where randomized withdrawal against standard of care provides the evidentiary basis for label expansion. Completion positions this endothelin receptor antagonist for potential pediatric indication filing, addressing an unmet need in a patient population often treated off-label with adult-approved therapies. |
🛡️ | Safety & Cybersecurity | 7 of 9 this week |
|
Product Recall Burn Hazard Forever 21 Kids Disney Mickey Mouse Pajama Pants were recalled due to violation of federal flammability standards for children's sleepwear. The garments failed to meet the flame resistance requirements under the flammable fabrics regulations. →The Consumer Product Safety Commission's authority over children's sleepwear reflects elevated regulatory scrutiny when products intersect with vulnerable populations and fire safety standards. Forever 21's recall of Disney-branded pajama pants for failing to meet federal flammability standards triggers mandatory corrective action under 16 CFR 1615 and 1616, which require tight-fitting designs or flame-resistant fabrics for children's sleepwear sizes 9 months through 14 years. This marks another enforcement action in a product category where retailers face strict liability regardless of manufacturing origin. |
Product Recall Burn Hazard Cubimana Island Storm 3 In 1 Building Sets with LED Lights were recalled due to presence of button or coin batteries that are accessible without a tool. The batteries pose an ingestion hazard to young children, violating federal battery accessibility regulations. →The CPSC's recall of LED-equipped building sets underscores a persistent challenge with imported consumer products: lithium battery compliance. Small button batteries that fail to meet federal standards pose ingestion hazards, particularly for children — a violation that triggers mandatory recalls regardless of reported incidents. This action reflects the agency's zero-tolerance enforcement posture on battery safety standards, a regulatory priority that has driven hundreds of toy and electronics recalls over the past three years. |
Product Recall Safety Recall Tomum Hair Regrowth Treatment with Minoxidil spray bottles were recalled for failing to meet child-resistant packaging requirements. The products violated the Poison Prevention Packaging Act by lacking adequate child-resistant closures. →Class II recall — potentially hazardous but unlikely to cause serious harm. The FDA classified this minoxidil spray recall as Class II, indicating a temporary or medically reversible adverse health consequence is possible. Minoxidil, the only FDA-approved topical ingredient for hair regrowth, requires strict manufacturing controls because contamination or concentration errors can cause cardiovascular side effects. This product was sold over-the-counter, expanding the affected consumer base beyond prescription channels. |
Product Recall Tip-Over Hazard 17 Stories Furniture 14-Drawer Dressers were recalled due to tip-over hazard and violation of the federal mandatory stability standard for clothing storage units. The dressers fail to meet ASTM F2057-23 requirements for furniture stability. →The Consumer Product Safety Commission has flagged these 14-drawer dressers for tip-over risk — a hazard class that historically draws heightened regulatory scrutiny following the 2022 STURDY Act, which mandated more stringent furniture stability testing. Multi-drawer units like this remain among the most frequently recalled furniture categories, particularly when they fail to meet the industry's voluntary ASTM F2057 standard that preceded the federal regulation. |
Product Recall Tip-Over Hazard LIVEHOM 11-Drawer Dressers were recalled for tip-over hazard and noncompliance with the federal mandatory stability standard for clothing storage units. The products do not meet the ASTM F2057-23 furniture stability requirements. →The CPSC's enforcement of tip-over standards for furniture continues to target high-drawer-count units following 2024's STURDY Act implementation. Dressers with 11 drawers represent a particularly high-risk category in recent recalls, as units over 30 inches in height require third-party stability testing and must meet specific tip-over resistance thresholds that many imported furniture lines failed to address during design. |
Product Recall Safety Recall ProRider Bicycle Helmets were recalled for failure to comply with the federal safety standard for bicycle helmets. The helmets do not meet the requirements of CPSC's bicycle helmet regulation at 16 CFR part 1203. →The Consumer Product Safety Commission reports approximately 33,000 bicycle helmet-related incidents annually, making this ProRider recall part of a product category under heightened regulatory scrutiny. Helmet recalls typically stem from impact protection failures or strap defects that compromise CPSC certification standards—both of which carry mandatory reporting requirements and can trigger multi-year compliance monitoring for the manufacturer. |
Product Recall Ingestion Hazard Kluster Fun Tabletop Magnet Chess Games were recalled due to presence of loose magnet sets that violate the federal magnet set regulation. The products contain high-powered magnets that pose an ingestion hazard, violating 16 CFR part 1262. →The Consumer Product Safety Commission ordered a recall of approximately 600 units of magnetic chess sets sold exclusively through Amazon.com, following reports of magnet detachment that created an ingestion hazard — a violation triggering mandatory recall under 16 CFR Part 1262. Small magnet ingestion represents one of the agency's highest-priority enforcement areas, with the CPSC maintaining a near-zero tolerance policy for loose magnets in consumer products since updating its magnet set safety standard in 2022. |
Also Filed Today · A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients With Previously Treated Non-Squamous NSCLC — PHASE2 · Randomized Phase II Trial of Anti-Lag-3 and Anti-PD-1 Blockade vs. SOC in Patients With Recurrent Glioblastoma — PHASE2 · A Randomized Phase II Study Comparing Cytarabine + Daunorubicin (7+3) vs (Daunorubicin and Cytarabine) Liposome, Cytarabine + Daunorubicin + Venetoclax, Azacitidine + Venetoclax, and (Daunorubicin and Cytarabine) Liposome + Venetoclax in Patients Aged 59 or Younger Who Are Considered High-Risk (Adverse) Acute Myeloid Leukemia As Determined by MYELOMATCH; A MYELOMATCH Clinical Trial — PHASE2 · Phase II Study of Osimertinib (AZD9291) in Advanced NSCLC Patients With Exon 20 Insertion Mutations in EGFR — PHASE2 · A Randomized Phase II/III Study of Azacitidine in Combination With Lenalidomide (NSC-703813) vs. Azacitidine Alone vs. Azacitidine in Combination With Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) — PHASE2 · Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial(ELEVATE-AF) — NA · A Randomized Phase II Study of Venetoclax and HMA-Based Therapies for the Treatment of Older and Unfit Adults With Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML): A MyeloMATCH Treatment Trial — PHASE2 · A Phase IB and Randomized Phase II Trial of Megestrol Acetate With or Without Ipatasertib in Recurrent or Metastatic Endometrioid Endometrial Cancer — PHASE1, PHASE2 · Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab in Combination With Talazoparib in Patients With SLFN11 Positive Extensive Stage Small Cell Lung Cancer (ES-SCLC) — PHASE2 · A Phase II Study of Androgen Receptor (AR) Inhibition by Darolutamide in Combination With Leuprolide Acetate and Exemestane in Recurrent Adult-Type Ovarian Granulosa Cell Tumor — PHASE2 · Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma — PHASE2 · Phase 2 Randomized Trial of Neoadjuvant or Palliative Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma — PHASE2 · Phase 2 Study of Paclitaxel (NSC #673089) + Ipatasertib (NSC #781451) in Taxane-Refractory Participants With PTEN/AKT-Altered Advanced Non-Breast Solid Tumors: A ComboMATCH Treatment Trial — PHASE2 · A Randomized Phase II Trial of Intermittent Versus Continuous Dosing of Dabrafenib (NSC-763760) and Trametinib (NSC-763093) in BRAF V600E/K Mutant Melanoma — PHASE2 · Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer — PHASE2 |
💬 What’s your take? Think we got the read wrong? Reply and tell us why. |
Spread The Word Know someone who’d find this useful? |
Recommended For You 🏛️ The Capitol Desk Today’s filings touched on policy and government activity. Get the full congressional picture every Monday. Learn More → |
More From The Filing Cabinet Free newsletters covering every angle of S&P 500 intelligence. | ⚡ | The Daily Filing SEC filings, insider moves, and market intelligence in a 5-minute morning briefing. | Daily |
| | 🏛️ | The Capitol Desk Congressional trades, lobbying disclosures, and legislation impacting public companies. | Weekly |
| | 📡 | The Signal Board Insider clusters, dark pool activity, 13F changes, and smart money flows. | Weekly |
| | 🔍 | The Deep Dive Long-form sector analysis, thematic research, and data-driven market context. | Weekly |
|
|
The Filing Cabinet © 2026 The Filing Cabinet. All rights reserved. Past performance is not indicative of future results. This is not financial advice. The Regulatory Pulse is for informational purposes only. Not professional advice. Did someone forward you this? Subscribe to this newsletter. Unsubscribe |
|